Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1094759-93-9

Post Buying Request

1094759-93-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1094759-93-9 Usage

General Description

4-chloro-5-fluoro-2-iodoaniline is a chemical compound with the formula C6H5ClFIN. It is a derivative of aniline and contains chlorine, fluorine, and iodine atoms attached to a benzene ring. 4-chloro-5-fluoro-2-iodoaniline is commonly used as an intermediate in the synthesis of pharmaceuticals, dyes, and agrochemicals. It is also used in organic chemistry as a building block for more complex molecules. 4-chloro-5-fluoro-2-iodoaniline has the potential to be hazardous if not handled and disposed of properly, and proper safety precautions should be taken when working with this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1094759-93-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,4,7,5 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1094759-93:
(9*1)+(8*0)+(7*9)+(6*4)+(5*7)+(4*5)+(3*9)+(2*9)+(1*3)=199
199 % 10 = 9
So 1094759-93-9 is a valid CAS Registry Number.

1094759-93-9Relevant articles and documents

ERBB/BTK INHIBITORS

-

Page/Page column 156; 90; 60, (2019/08/26)

Disclosed are compounds inhibiting ErbBs (e. g., EGFR or Her 2), especially mutant forms of ErbBs, and BTK, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compou

ARYL-QUINOLINE DERIVATIVES

-

Paragraph 0940; 0941, (2013/05/21)

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and n are as described herein, compositions including the compounds and methods of using the compounds. The present compounds are useful as fatty-acid binding protein (FABP) 4 and/or 5 inhibitors and may be used for the treatment or prophylaxis of lipodystrophy, type 2 diabetes, dyslipidemia, atherosclerosis, liver diseases involving inflammation, steatosis and/or fibrosis, such as non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis, metabolic syndrome, obesity, chronic inflammatory and autoimmune inflammatory diseases.

SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS

-

Paragraph 00223, (2013/04/25)

The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1094759-93-9